Event

The ATS is a vital partner in NCI’s Cancer Moonshot. Soon, lung cancer care and research will be characterized by molecular diagnosis and targeted treatment and will be personalized, safe, effective and affordable. This symposium will highlight three areas along the lung cancer continuum that are most relevant for ATS members including 1) prevention and screening, 2) nodules and early detection, and 3) development of novel therapies to treat early stage disease. Each speaker will discuss at least one Moonshot focus including, early cancer detection, immunotherapy and combination therapies, genomic profiling of tumor and surrounding cells, and enhanced data sharing.